Article
Malignant glioma drug discovery – targeting protein kinases
1 Jan 2007
Abstract excerpt
Malignant gliomas are uncommon, but extremely lethal, cancers. Current standard-of-care includes surgery, radiation and chemotherapy, but recent research has generated a shift towards targeting the aberrant signal transduction components that underlie the pathogenesis of malignant gliomas. Protein kinases are a family of enzymes that are key elements in signal transduction-regulated cellular homeostasis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
